| Theravance Reports First Quarter 2010 Financial Results - MarketWatch (press release) |
|
|
MarketWatch (press release)New onset or worsening renal impairment occurred in patients who received VIBATIV. Renal adverse events were more likely to occur in patients with baseline ... read more |